More courageous advocacy providing hope that those prescribed SSRIs may be better informed. Of utmost importance: – a chance for patient and prescriber to be aware of the most dangerous of the psychotropic drug induced toxicities – AKATHISIA. The Court Transcripts – (Dolin v GSK) Chicago 2017 reveal how the dangers of SSRI induced akathisia had been allegedly hidden from prescribers and their patients by the both SSRI manufactures and the drug regulators. AKATHISIA. 1 in 5 of patients taking SSRIs will have clinically significant akathisia. As high as 50% with antipsychotics. The suffering of the patient and that of their loved ones is profound. The intense and increasing agitation, pacing, iatrogenic change in behaviour and personality, aggression and acute neurotoxicity-induced self harm, violence against self or others predispose to incompetent and erroneous misdiagnosis of serious mental illness (SMI) where none exists. Such failure of basic differential diagnosis may result in detention and enforced “medication” with more of the same classes of drugs that induced this life threatening adverse drug reaction. (ADR). There appears little medical interest in the potential to prevent akathisia and its incumbent risk of iatrogenic suicidality and completed suicide by using genomic sequencing tests to identify those who have an impaired ability to metabolise prescription psychoactive drugs. Thank you Katinka. TRM 123. Retired Consultant Physician.